相关实验视频
Updated: Jun 25, 2026
11:01
Monitoring Plant Hormones During Stress Responses
Published on: June 15, 2009
16.6K
使用GC-MS对三种药用植物的挥发性化合物进行植物化学查和特征鉴定,这些药物据报有抗癌特性
Emelinah Mathe1, Lesibana Sethoga2, Sipho Mapfumari1
1Department of Biochemistry and Biotechnology, School of Science and Technology, Sefako Makgatho Health Sciences University, Pretoria 0208, South Africa.
Life (Basel, Switzerland)
|November 27, 2024
概括
南非的药用植物Annona senegalensis,Sutherlandia frutescens和Withhania somnifera含有有价值的植物化学物质. 它们的叶子产生的挥发性化合物对于治疗癌症和糖尿病等疾病很重要.
科学领域:
- 植物化学 植物化学
- 民族植物学 民族植物学
- 分析化学 分析化学
背景情况:
- 南非有Annona senegalensis,Sutherlandia frutescens和Withhania somnifera,它们在南非普遍存在.
- 这些植物传统上被治疗师用于治疗各种疾病,包括癌症.
研究的目的:
- 为了对三个植物进行植物化学选.
- 用气相色谱-质谱法 (GC-MS) 描述挥发性化合物.
主要方法:
- 甲醇叶提取物被用于通过标准化学试验进行植物化学查.
- 使用GC-MS分析了挥发性化合物,并根据NIST08库进行了识别.
主要成果:
- 植物化学查揭示了类化合物,类化合物,类固醇,心脏糖化物,氨酸和类化合物.
- 在三种物种中,GC-MS确定了19种具有已知的生物活性的挥发性化合物.
结论:
- 安诺娜·塞内加拉尼斯 (Annona senegalensis),萨瑟兰地 (Sutherlandia frutescens) 和维坦尼亚·索姆尼菲拉 (Withhania somnifera) 的叶子是生物活性植物化学物质的丰富来源.
- 这些发现在科学上证实了它们在治疗癌症和糖尿病等严重疾病中的传统用途.
关键词:
安诺娜·塞内加尔人种 (Annona senegalensis) 是一个萨瑟兰的果实生长.这种植物叫Withhania somnifera.生物活动是生物活动.植物成分 植物成分植物提取物植物提取物更多相关视频
相关概念视频
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...